Skip to search formSkip to main contentSkip to account menu

fumagillol

Known as: 1-Oxaspiro(2.5)octan-6-ol, 5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-, (3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An efficient, two-step construction of highly complex alkaloid-like compounds from the natural product fumagillol is described… 
2009
2009
Inhibition of methionine aminopeptidase-2 (MetAP2) represents a novel approach to antiangiogenic therapy. We describe the… 
2001
2001
[reaction: see text]. A new strategy to access the fumagillin/fumagillol skeleton is proposed. An Evans aldolization and a RCM… 
1999
1999
A 13-step synthesis of (±)-fumagillol (1), the direct precursor of the potent angiogenesis inhibitors TNP-470 and fumagillin… 
Review
1996
Review
1996
Angiogenesis is required for the development of many proliferative diseases, including granulomatous disease, such as rheumatoid… 
1994
1994
Accumulated knwoledge regarding the important roles played by angiogenesis in solid tumor growth and metastasis has prompted the…